Westside Investment Management »

Vaneck Vectors Pharmaceutical etf shares owned by Westside Investment Management

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Westside Investment Management from 13F filings

Historical chart of Westside Investment Management investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Westside Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Westside Investment Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $222k 2.4k 94.26
2025-06-30 $208k 2.4k 88.41

More positions owned by Westside Investment Management

Apple (AAPL)
Vanguard High Etf (VYM)
Vanguard Total Etf (VTI)
Invesco Qqq Etf (QQQ)
Tutor Perini Corporation (TPC)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Uber Technologies (UBER)
Alphabet Inc Class A cs (GOOGL)
Facebook Inc cl a (META)
Eton Pharmaceuticals (ETON)
Ishares Core Etf (IEFA)
Ishares Core Etf (AGG)
Harrow Health (HROW)
Broadcom (AVGO)

View all positions for Westside Investment Management

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Morgan Stanley
Wells Fargo & Company
Clal Insurance Enterprises Holdings
J.Safra Asset Management
Avalon Trust
Jpmorgan Chase & Co
J. Goldman & Co
Miller Investment Management
Jane Street
Revere Asset Management
Adamsbrown Wealth Consultants
Bnp Paribas Arbitrage, Snc
Prime Capital Investment Advisors

View all funds holding Vaneck Vectors Pharmaceutical etf